A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Status:
Completed
Trial end date:
2014-08-05
Target enrollment:
Participant gender:
Summary
This study was conducted to determine the efficacy and safety of GWP42003 compared with
placebo by the percentage of participants achieving remission quantified as a Mayo score of 2
or less (with no sub-score >1) after 10 weeks of treatment.